UK markets closed

Revolution Medicines, Inc. (RVMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
40.20+1.01 (+2.58%)
At close: 04:00PM EDT
40.98 +0.78 (+1.94%)
After hours: 05:17PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-436,367
-436,367
-248,705
-187,091
-108,159
Depreciation & amortisation
9,309
9,309
9,656
7,332
6,545
Stock-based compensation
61,772
61,772
31,196
20,724
8,886
Change in working capital
36,752
36,752
-13,489
8,724
-8,304
Accounts receivable
3,419
3,419
1,256
464
2,344
Accounts payable
32,469
32,469
7,288
2,239
305
Other working capital
-358,301
-358,301
-235,217
-153,708
-102,997
Net cash provided by operating activities
-350,572
-350,572
-224,401
-147,180
-100,064
Cash flows from investing activities
Investments in property, plant and equipment
-7,729
-7,729
-10,816
-6,528
-2,933
Purchases of investments
-1,058,916
-1,058,916
-612,769
-671,335
-544,133
Sales/maturities of investments
724,047
724,047
599,469
535,746
312,833
Net cash used for investing activities
-342,598
-342,598
-24,116
-142,117
-234,233
Cash flows from financing activities
Common stock issued
385,759
385,759
298,045
291,241
420,067
Other financing activities
836,808
836,808
42
-424
-
Net cash used provided by (used for) financing activities
1,229,200
1,229,200
301,432
294,179
422,776
Net change in cash
536,030
536,030
52,915
4,882
88,479
Cash at beginning of period
163,149
163,149
110,234
105,352
16,873
Cash at end of period
699,179
699,179
163,149
110,234
105,352
Free cash flow
Operating cash flow
-350,572
-350,572
-224,401
-147,180
-100,064
Capital expenditure
-7,729
-7,729
-10,816
-6,528
-2,933
Free cash flow
-358,301
-358,301
-235,217
-153,708
-102,997